Signature Devices (SDVI) and Nano 101, a lead CBD topical patch maker announce strong Q2 financial results for 2019

Signature Devices, Inc. (OTC PINK: SDVI), and its subsidiary Nano 101, today announced the release of its Q2 financials report for 2019. Included in the report are financials that incorporate Nano 101 Technology and Innovo Technology revenue.

The company announced a revenue growth of 120% from the same period as 2018, and a 95% growth from Q1 2019.

The company also reported a net income of $27k, which is a 300% increase from the previous quarter.

The primary driver of the increase in revenue is growing demand for Nano 101’s CBD and Hemp patches, which are sold through its ecommerce sites and Amazon.

About Nano 101

Based in Irvine, California, Nano 101, Inc. (www.nano101.io) was founded by a diverse set of individuals, including physicians, clinical researchers, naturopaths and botanists, who all have had a strong history and interest in hemp-based therapeutics. The goal of the company has been to combine the latest hemp-based therapeutics with the latest topical delivery systems.

About Signature Devices, Inc.

Based in Sheridan, Wyoming, Signature Devices, Inc. (www.signaturedevices.com) (OTC PINK: SDVI) is a holding company with various subsidiaries that develop Internet of Things (IOT) products through its subsidiary Innovo Technologies, Inc., and publishes diverse media products including video games and mobile applications through its subsidiary Graffiti Entertainment, Inc.

Forward-Looking Statements:

The information in this press release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

Signature Devices, Inc. Investors Relations [email protected] 650-654-4800 ext 111 http://www.signaturedevices.com